Humoral immune response of a heterologous vaccination between BBIBP-CorV and BNT162b2 with a temporal separation of 7 months, in Peruvian health workers, with and without a history of SARS-CoV-2 infection

This database corresponds to the humoral immunological results from health workers (in a private clinical laboratory) in Peru, who received the first two doses of BBIBP-CorV and seven months later a heterologous booster with BNT162b2. We employed two immunochemical assays to obtain the amount of neutralizing antibodies: Elecys® anti-SARS-CoV-2 S and the cPass™ SARS-CoV-2 Neutralization Antibody assays to evaluate anti-S-RBD IgG and NAbs, respectively.

本数据集收录了秘鲁某私立临床实验室医护人员的体液免疫学检测结果。该受试群体先后完成两剂BBIBP-CorV疫苗接种，并在末次基础免疫七个月后，接受了基于BNT162b2的异源加强针接种。本研究采用两种免疫化学检测方法以定量检测中和抗体滴度：其中Elecys®抗SARS-CoV-2 S抗体检测试剂盒用于检测抗S-RBD IgG抗体，cPass™ SARS-CoV-2中和抗体检测试剂盒用于检测中和抗体（neutralizing antibodies, NAbs）。